AR228256A1 - PROCEDURE FOR THE ELABORATION OF NEW COMPOUNDS OF 2- (PIRIMIDINILAMINO) -1,3-DIAZA-2-CICLOALQUENO - Google Patents

PROCEDURE FOR THE ELABORATION OF NEW COMPOUNDS OF 2- (PIRIMIDINILAMINO) -1,3-DIAZA-2-CICLOALQUENO

Info

Publication number
AR228256A1
AR228256A1 AR281109A AR28110980A AR228256A1 AR 228256 A1 AR228256 A1 AR 228256A1 AR 281109 A AR281109 A AR 281109A AR 28110980 A AR28110980 A AR 28110980A AR 228256 A1 AR228256 A1 AR 228256A1
Authority
AR
Argentina
Prior art keywords
pirimidinilamino
cicloalqueno
diaza
elaboration
procedure
Prior art date
Application number
AR281109A
Other languages
Spanish (es)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AR228256A1 publication Critical patent/AR228256A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR281109A 1979-05-18 1980-05-19 PROCEDURE FOR THE ELABORATION OF NEW COMPOUNDS OF 2- (PIRIMIDINILAMINO) -1,3-DIAZA-2-CICLOALQUENO AR228256A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH466979 1979-05-18

Publications (1)

Publication Number Publication Date
AR228256A1 true AR228256A1 (en) 1983-02-15

Family

ID=4280399

Family Applications (1)

Application Number Title Priority Date Filing Date
AR281109A AR228256A1 (en) 1979-05-18 1980-05-19 PROCEDURE FOR THE ELABORATION OF NEW COMPOUNDS OF 2- (PIRIMIDINILAMINO) -1,3-DIAZA-2-CICLOALQUENO

Country Status (21)

Country Link
EP (1) EP0019811A1 (en)
JP (1) JPS55154971A (en)
KR (1) KR830002757A (en)
AR (1) AR228256A1 (en)
AU (1) AU5848480A (en)
DD (1) DD150609A5 (en)
DK (1) DK214480A (en)
ES (1) ES491514A0 (en)
FI (1) FI801600A (en)
GB (1) GB2052487B (en)
GR (1) GR68453B (en)
IE (1) IE49803B1 (en)
IL (1) IL60086A (en)
MA (1) MA18829A1 (en)
NO (1) NO801469L (en)
NZ (1) NZ193730A (en)
OA (1) OA06533A (en)
PL (1) PL224313A1 (en)
PT (1) PT71251A (en)
ZA (1) ZA802909B (en)
ZW (1) ZW11880A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507146A (en) * 1982-12-28 1985-03-26 Ciba-Geigy Corporation 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity
DE3829469A1 (en) * 1988-08-31 1990-03-01 Bayer Ag METHOD FOR THE PRODUCTION OF SUBSTITUTED N-AZINYL-N'-SULFONYL-ISOTHIO-UREAS AND N-AZINYL-IMINODITHIOCARBONIC ACID-S, S-DIESTER AS INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION
CA2269971A1 (en) * 1997-09-03 1999-03-11 Trent Lee Abraham Pyrimidine derivatives
AU2001291013A1 (en) 2000-09-15 2002-03-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
HUP0400908A3 (en) 2000-12-21 2010-03-29 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors, their use and pharmaceutical compositions containing them
AU2002247149B2 (en) * 2001-01-31 2007-10-25 H. Lundbeck A/S Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
DK1483247T3 (en) 2002-03-13 2009-08-17 Euro Celtique Sa Aryl-substituted pyrimidines and their use
EP1484971B1 (en) * 2002-03-15 2007-07-04 Ciba SC Holding AG Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
EP1485380B1 (en) 2002-03-15 2010-05-19 Vertex Pharmaceuticals Incorporated Azolylaminoazines as inhibitors of protein kinases
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
ES2273043T3 (en) 2002-08-02 2007-05-01 Vertex Pharmaceuticals Incorporated PIRAZOL COMPOSITIONS USEFUL AS INHIBITORS OF GSK-3.
WO2004072029A2 (en) 2003-02-06 2004-08-26 Vertex Pharmaceuticals Incorporated Pyrazolopyridazines useful as inhibitors of protein kinases
AU2006279376B2 (en) 2005-08-18 2011-04-14 Vertex Pharmaceuticals Incoporated Pyrazine kinase inhibitors
US7528142B2 (en) 2005-11-03 2009-05-05 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
AU2007317435A1 (en) 2006-11-02 2008-05-15 Vertex Pharmaceuticals Incorporated Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
NZ577768A (en) 2006-12-19 2012-01-12 Vertex Pharma Aminopyrimidines useful as inhibitors of protein kinases
JP2010520887A (en) 2007-03-09 2010-06-17 バーテックス ファーマシューティカルズ インコーポレイテッド Aminopyridines useful as inhibitors of protein kinases
ES2435997T3 (en) 2007-03-09 2013-12-26 Vertex Pharmaceuticals, Inc. Aminopyrimidines useful as protein kinase inhibitors
JP5393489B2 (en) 2007-03-09 2014-01-22 バーテックス ファーマシューティカルズ インコーポレイテッド Aminopyrimidines useful as inhibitors of protein kinases
CN101679386A (en) 2007-04-13 2010-03-24 沃泰克斯药物股份有限公司 Aminopyrimidines useful as kinase inhibitors
EP2152696B1 (en) 2007-05-02 2014-09-24 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
EP2152694A2 (en) 2007-05-02 2010-02-17 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
ES2400104T3 (en) 2007-07-31 2013-04-05 Vertex Pharmaceuticals Incorporated Process for preparation of 5-fluoro-1H-pyrazolo [3,4-b] pyridin-3-amine and derivatives thereof
WO2010027921A1 (en) 2008-09-03 2010-03-11 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same
PT2364314E (en) * 2008-12-09 2014-06-09 Gilead Sciences Inc Modulators of toll-like receptors
KR102328682B1 (en) * 2018-08-27 2021-11-18 주식회사 대웅제약 Novel heterocyclicamine derivatives and pharmaceutical composition comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (en) * 1969-08-14 1971-02-15 Beecham Group Ltd IMINAZOLINES

Also Published As

Publication number Publication date
DK214480A (en) 1980-11-19
IL60086A (en) 1984-03-30
DD150609A5 (en) 1981-09-09
GR68453B (en) 1981-12-30
FI801600A (en) 1980-11-19
ZA802909B (en) 1981-05-27
NO801469L (en) 1980-11-19
KR830002757A (en) 1983-05-30
PL224313A1 (en) 1981-02-13
ZW11880A1 (en) 1980-12-17
IE801023L (en) 1980-11-18
NZ193730A (en) 1982-12-21
EP0019811A1 (en) 1980-12-10
ES8104279A1 (en) 1981-04-16
IL60086A0 (en) 1980-07-31
JPS55154971A (en) 1980-12-02
PT71251A (en) 1980-06-01
GB2052487A (en) 1981-01-28
GB2052487B (en) 1983-05-11
AU5848480A (en) 1980-11-20
OA06533A (en) 1981-07-31
IE49803B1 (en) 1985-12-25
ES491514A0 (en) 1981-04-16
MA18829A1 (en) 1980-12-31

Similar Documents

Publication Publication Date Title
AR228256A1 (en) PROCEDURE FOR THE ELABORATION OF NEW COMPOUNDS OF 2- (PIRIMIDINILAMINO) -1,3-DIAZA-2-CICLOALQUENO
ES514585A0 (en) PROCEDURE FOR THE OBTAINING OF TRISUSTITUIDED OXAZOL DERIVATIVES.
AR224008A1 (en) PROCEDURE FOR PREPARING POLYHIDRO-3,7-DIMETIL-8- (2- (TETRAHIDRO-4-HIDROXI-6-OXO-2H-PIRAN-2-IL) -ETIL) -1-NAFTIL-2-METHYLBUTYRATE
ES535946A0 (en) PROCEDURE FOR PREPARING 2- (2-BENZOIL SUBSTITUTED) -1, 3-CYCLOHEXANODIONAS
ES488196A0 (en) PROCEDURE FOR THE PREPARATION OF DIOXACINABASIC COMPOUNDS
AR230437A1 (en) PROCEDURE FOR THE MANUFACTURE OF DERIVATIVES OF 2- (DIALQUAMINO, PIRROLIDINIL OR PIPERIDINIL) -ALQUIL-TIO-QUINOLINA
AR227527A1 (en) PROCEDURE FOR THE ELABORATION OF NEW COMPOUNDS N-OXACICLILALQUIL-PIPERIDIL-DIAZOICOS
ES493846A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW OLIGOLIPID COMPOUNDS.
ES497366A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW MERCAPTOORGANOSILOXANE COMPOUNDS.
ES491341A0 (en) PROCEDURE FOR THE OBTAINING OF FUMORATED DERIVATIVES OF TRIAZOLIL-BUTANE, OF FUNGICIDE EFFECT
AR227286A1 (en) PROCEDURE FOR THE ELABORATION OF NEW COMPOUNDS OF 1- (2-IMIDAZOLIDIN-1-ILO-ALQUIL) -3-FENILUREA OR TIOUREA
ES489689A0 (en) PROCEDURE FOR PREPARING ISOTIOUREA COMPOUNDS
MX6580E (en) PROCEDURE FOR THE PREPARATION OF ACETOXIMETIL-PENAM COMPOUNDS
ES493499A0 (en) PROCEDURE FOR PREPARING 3-METHYLEMAZETIDINE COMPOUNDS
AR224318A1 (en) PROCEDURE FOR THE PREPARATION OF PIRAN-4-ONA COMPOUNDS
AR213659A1 (en) PROCEDURE FOR THE PREPARATION OF 2- (4- (AROIL OR HETEROAROIL) -PIPERAZIN-1-IL) -4-AMINO-6,7-DIMETOXYQUINAZOLINES
ES488709A0 (en) PROCEDURE FOR THE PREPARATION OF DIORGANOMAG-NESICOS COMPOUNDS, R2MG
AR223319A1 (en) PROCEDURE FOR THE ELABORATION OF 6-AMINO-PENAM COMPOUNDS
ES493016A0 (en) PROCEDURE FOR THE PREPARATION OF NEW 2- (PERHI-DRO-1,4-DIAZINO) -PIRIMIDO (5,4-D) PIRIMIDINAS
ES494211A0 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 10-HALOGEN-E-HOMO-EBURNANOS.
AR229174A1 (en) PROCEDURE FOR THE PREPARATION OF NEW 4- (3-TRIFLUORMETILFENIL) -1,2,3,6-TETRAHIDROPIRIDINAS
AR216675A1 (en) PROCEDURE FOR THE PREPARATION OF 2- (GAMMA- (1-PIPERIDINIL) PROPIL) -1,2-BENZISOTIAZOL-3-ONA
ES496509A0 (en) PROCEDURE FOR THE PREPARATION OF NEW CATIONIC COMPOUNDS
MX5101E (en) PROCEDURE FOR THE PREPARATION OF 2- (2 ', 2', 2 ', - TRIHALOGENOETIL) -4-HALOGENOCICLOBUTAN-1-ONAS
ES497784A0 (en) PROCEDURE FOR THE PREPARATION OF GUANIDINIO COMPOUNDS.